Risk Factors That Affect Survival in Patients with Renal Cell Carcinoma Invading the Vena Cava
- 1 Department of Urology, Lahey Hospital and Medical Center, Burlington, MA, USA
- 2 Department of Urology, Lahey Hospital and Medical Center, Burlington, MA, USA
- 3 Department of Urology, Lahey Hospital and Medical Center, Burlington, MA, USA
Abstract
Objectives: To determine which risk factors are associated with overall survival in patients with T3b or T3c renal cell carcinoma. Materials and Methods: Retrospective chart review was performed on all patients who underwent a nephrectomy at Lahey Hospital from 1971-2014 and had a diagnosis of pathologic T3b or T3c renal cell carcinoma. Twenty-one potential risk factors were examined and analyzed using Cox Proportional Hazard Survival models. Additional factors examined in this cohort included rate of complications, tumor recurrence, intra-operative death rate, and 30-day mortality rate. Results: One-hundred eighty-two patients with stage T3b or T3c renal cell carcinoma met inclusion criteria. Of these, 124 (68%) were stage T3b and 58 (32%) were stage T3c. Median follow-up was 18.5 months. One-hundred and six (58%) patients experienced a complication from surgery. The intra-operative death rate was 1.1% (2 patients). The 30-day mortality rate was 7.1% (13 patients). Seventy-one (39%) patients had disease recurrence at a median of 7 months (range 1 - 232 months). The 5-year disease-specific survival was 40% and the 5-year overall survival was 32%. Of the 21 risk factors analyzed, clear cell histology, positive lymph nodes, and peri-nephric fat involvement were all significant at the p < 0 .05 level using unadjusted modeling. On multivariable analysis, fully adjusting for all three significant variables, only positive lymph nodes and peri-nephric fat involvement remained significant. Conclusions: In patients with T3b or T3c renal cell carcinoma overall survival is associated with lymph node positivity and peri-nephric fat involvement and not tumor thrombus level.
- Gupta, K., Miller, J.D., Li, J.Z., et al. (2008) Epidemiologic and Socioeconomic Burden of Metastatic Renal Cell Carcinoma (mRCC): A Literature Review. Cancer Treatment Reviews, 34, 193. https://doi.org/10.1016/j.ctrv.2007.12.001
- Marshall, F., Dietrick, D., Baumgartner, W., et al. (1988) Surgical Management of Renal Cell Carcinoma with Intracaval Neoplastic Extension above the Hepatic Veins. Journal of Urology, 139, 1166.
- Wagner, B., Patard, J.J., Me Jean, A., et al. (2009) Prognostic Value of Renal Vein and Inferior Vena Cava Involvement in Renal Cell Carcinoma. European Urology, 55, 452. https://doi.org/10.1016/j.eururo.2008.07.053
- Haferkamp, A., Bastian, P.J., Jakobi, H., et al. (2007) Renal Cell Carcinoma with Tumor Thrombus Extension into the Vena Cava: Prospective Long-Term Followup. Journal of Urology, 177, 1703. https://doi.org/10.1016/j.juro.2007.01.039
- Edge, S.B. and Compton, C.C. (2010) The American Joint Committee on Cancer: The 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM. Annals of Surgical Oncology, 17, 1471. https://doi.org/10.1245/s10434-010-0985-4
- Martinez-Salamanca, J.I., Linares, E., Gonzales, J., et al. (2014) Lessons Learned from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC). Current Urology Reports, 15, 404. https://doi.org/10.1007/s11934-014-0404-7
- Ficarra, C., Novara, G., Infrate, M., et al. (2007) Proposal for Reclassification of the TNM Staging System in Patients with Locally Advanced (pT3-4) Renal Cell Carcinoma According to the Cancer-Related Outcome. European Urology, 51, 722. https://doi.org/10.1016/j.eururo.2006.07.010
- Moinzadeh, A. and Libertino, J. (2004) Prognostic Significance of Tumor Thrombus Level in Patients with Renal Cell Carcinoma and Venous Tumor Thrombus Extention. Is All T3b the Same? Journal of Urology, 171, 598. https://doi.org/10.1097/01.ju.0000108842.27907.47
- Gettman, M., Boelter, C., Cheville, J., et al. (2003) Charlson Comorbidity Index as a Predictor of Outcome after Surgery for Renal Cell Carcinoma with Renal Vein, Vena Cava or Right Atrium Extension. Journal of Urology, 169, 1282. https://doi.org/10.1097/01.ju.0000049093.03392.cc
- Frank, L., Blute, M., Cheville, J., et al. (2002) An Outcome Prediction Model for Patients with Clear Cell Renal Cell Carcinoma Treated with Radical Nephrectomy Based on Tumor Stage, Size, Grade, and Necrosis: The SSIGN Score. Journal of Urology, 168, 2395. https://doi.org/10.1016/S0022-5347(05)64153-5